Home

Blog

How People Voted

8% For, 92% Against

Take Action

Alert Your Friends and Colleagues
Write Your Representative in Congress
Save & Share
del.icio.us
Digg
Facebook
Google
Reddit
Yahoo!

H.R. 3023, The Drug and Medical Device Company Gift Disclosure Act

  • This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

Comparing original version (created by webmaster) with revision saved on October 10, 2007, 14:50:19 (webmaster):

H.R. 3023 would require the manufacturers, packers, and distributors of prescription drugs and medical devices to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities.

== Detailed Summary ==

<summary>
(Log inDrug and Medical Device Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require prescription drug or medical device manufacturers, packers, and distributors to annually disclose to edit the wikiCommissioner of Food and beDrugs the firstvalue, nature, and purpose of any : (1) gift made in connection with detailing, promotion, or other marketing activity to provideany physician, nurse, therapist, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person authorized to prescribe or dispense prescription drugs; and (2) cash rebate, discount, or other financial consideration given to any pharmaceutical benefit manager in connection with such marketing activities. Defines &quot;gift&quot; to include any fee, payment, subsidy, amenity, object, service, or other economic benefit, except: (1) free samples of prescription drugs; (2) reasonable compensation and reimbursement of expenses in connection with a detailed summarybona fide clinical trial; and (3) certain scholarships or other support for medical students, residents, or fellows to attend conferences. Applies such provisions only if the total value of the bill!)gift or gifts is $50 or more during the calendar year.

Requires the Commissioner to: (1) make such information available to the public; and (2) keep confidential any information related to a trade secret. Establishes civil penalties for violations.

Gives the Commissioner authority to investigate compliance with this Act. Authorizes the Commissioner to file a petition in the United States District Court for an order requiring submission of a report or other appropriate relief.

</summary>

<!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. -->

== Status of the Legislation ==

<status>
(Log inLatest Major Action: 7/12/2007: Referred to House committee. Status: Referred to edit the wikiHouse Committee on Energy and be the first to update the status of the bill!)Commerce.
</status>

<!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. -->

== Points in Favor ==

(Log in to edit the wiki and be the first to show why the bill should pass!)
<!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! -->

== Points Against ==

(Log in to edit the wiki and be the first to show why the bill should not pass!)
<!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! -->

« Return to Revision History.


Visitor Comments Comments Feed for This Bill

There are currently no comments for this bill.

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)